24095-56-5 Usage
General Description
N-[4-(Chloroacetyl)benzyl]acetamide is a chemical compound that belongs to the class of N-substituted acetamides. It is characterized by the presence of a benzyl group with a chloroacetyl moiety, attached to an acetamide functional group. N-[4-(CHLOROACETYL)BENZYL]ACETAMIDE is commonly used in organic synthesis and pharmaceutical research, where it serves as a building block for the preparation of various biologically active compounds. N-[4-(Chloroacetyl)benzyl]acetamide has potential applications in the development of new drugs and active pharmaceutical ingredients due to its ability to modulate biological processes and interact with enzyme targets. Additionally, it may also find use in the preparation of specialty chemicals and materials in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 24095-56-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,0,9 and 5 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 24095-56:
(7*2)+(6*4)+(5*0)+(4*9)+(3*5)+(2*5)+(1*6)=105
105 % 10 = 5
So 24095-56-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H12ClNO2/c1-8(14)13-7-9-2-4-10(5-3-9)11(15)6-12/h2-5H,6-7H2,1H3,(H,13,14)
24095-56-5Relevant articles and documents
Novel phenylpiperazine derivatives as dual cytokine regulators with TNF-α suppressing and IL-10 augmenting activity
Hanano, Tokushi,Adachi, Kunitomo,Aoki, Yoshiyuki,Morimoto, Hiroshi,Naka, Yoichi,Hisadome, Masao,Fukuda, Tetsuko,Sumichika, Hiroshi
, p. 875 - 879 (2007/10/03)
Phenylpiperazine derivatives were synthesized as dual cytokine regulators with TNF-α suppressing and IL-10 augmenting activity. Lead optimization led to compound 5k having the potent regulatory activity and demonstrating remarkable protective effects against the lethal challenge of LPS in mice, suggesting that 5k would be a promising drug candidate for the treatment of TNF-α associated diseases including septic shock. (C) 2000 Elsevier Science Ltd. All rights reserved.
